CartiHeal exits for half a billion

US giant Bioventus is acquiring Israel’s CartiHeal (see here previously) for $500 million. The decision came after a pivotal clinical trial of CartiHeal’s Agili-C knee cartilage implant.,7340,L-3916642,00.html

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *